These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33112465)

  • 1. Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review.
    Yang JJ; Maloney NJ; Nguyen KA; Worswick S; Smogorzewski J; Bach DQ
    Dermatol Ther; 2021 Jan; 34(1):e14461. PubMed ID: 33112465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic Dermatosis Limited to Lipo-Lymphedematous Skin in a Morbidly Obese Woman on Dasatinib Therapy.
    Ainechi S; Carlson JA
    Am J Dermatopathol; 2016 Feb; 38(2):e22-6. PubMed ID: 26825166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophilic dermatosis after azathioprine exposure.
    Cyrus N; Stavert R; Mason AR; Ko CJ; Choi JN
    JAMA Dermatol; 2013 May; 149(5):592-7. PubMed ID: 23677084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.
    Theroux Z; Gardner J; Ortiz E; Kosik G; Junkins-Hopkins J
    J Cutan Pathol; 2023 Oct; 50(10):884-889. PubMed ID: 37403191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sweet's syndrome, a diagnosis to keep in mind].
    Lang C; Quenan S
    Rev Med Suisse; 2017 Mar; 13(556):678-683. PubMed ID: 28722377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma].
    Ahangari D; Ngendahayo P; Colinet B; Roquet-Gravy PP
    Ann Dermatol Venereol; 2020 Mar; 147(3):202-206. PubMed ID: 32029299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole-induced Sweet syndrome: a new association.
    Baquerizo Nole KL; Lee E; Villada G; Romanelli P
    Am J Dermatopathol; 2015 May; 37(5):419-22. PubMed ID: 25590289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review.
    Ravi V; Maloney NJ; Worswick S
    Dermatol Ther; 2019 Sep; 32(5):e13074. PubMed ID: 31444856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet Syndrome: A Review and Update.
    Villarreal-Villarreal CD; Ocampo-Candiani J; Villarreal-Martínez A
    Actas Dermosifiliogr; 2016 Jun; 107(5):369-78. PubMed ID: 26826881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab-Associated Sweet Syndrome.
    Fernandez E; Chandler W; Long PR; Palmer ML; Fadugba O
    Cutis; 2023 Jun; 111(6):E7-E9. PubMed ID: 37487126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent and Fixed Neutrophilic Dermatosis Associated With Dasatinib.
    Bergman JC; Ly TY; Keating MM; Hull PR
    J Cutan Med Surg; 2018; 22(6):621-623. PubMed ID: 29754527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine hypersensitivity: A Sweet-like syndrome.
    Sivanandam LK; Begum B; Martinez EC; Garikipati S; Sanker V; Siddiq A
    Int J Rheum Dis; 2024 Jan; 27(1):e14817. PubMed ID: 37401805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib-induced Sweet's syndrome.
    Fye KH; Crowley E; Berger TG; LeBoit PE; Connolly MK
    J Am Acad Dermatol; 2001 Aug; 45(2):300-2. PubMed ID: 11464196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Sweet Syndrome Secondary to Pegfilgrastim.
    Clarey D; DiMaio D; Trowbridge R
    J Drugs Dermatol; 2022 Apr; 21(4):422-424. PubMed ID: 35389579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib mesylate-induced lichenoid drug eruption.
    Penn EH; Chung HJ; Keller M
    Cutis; 2017 Mar; 99(3):189-192. PubMed ID: 28398413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.
    Korkmaz M; Eryılmaz MK; Karaağaç M; Demirkıran A; Araz M; Artaç M
    J Oncol Pharm Pract; 2021 Jul; 27(5):1307-1310. PubMed ID: 33028131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic histiocytoid Sweet syndrome: a case report with clinical and histopathological considerations.
    Secchin P; Gomes MK; Quintella DC; Barata MCC; Machado HSV; Ramos-E-Silva M; Cuzzi T
    Int J Dermatol; 2018 Oct; 57(10):1182-1186. PubMed ID: 30113066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive.
    Tefany FJ; Georgouras K
    Australas J Dermatol; 1991; 32(1):55-9. PubMed ID: 1834046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.